California Nanotechnologies (FRA:R14) EBIT: €-1.65 Mil (TTM As of Nov. 2025)


FRA:R14 California Nanotechnologies Corp FRA:R14
40 GF Score
Price €0.14
GF Value €0.18
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is California Nanotechnologies EBIT?

California Nanotechnologies FRA:R14 -11.39% 40 EBIT is €-1.65 Mil as of Nov. 2025. GuruFocus rates FRA:R14 with a GF Score™ of 40/100 and a GF Value™ of €0.18 (Modestly Undervalued). The stock has 6 warning signs investors should review.

California Nanotechnologies's earnings before interest and taxes (EBIT) for the three months ended in Nov. 2025 was €-0.92 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Nov. 2025 was €-1.65 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. California Nanotechnologies's annualized ROC % for the quarter that ended in Nov. 2025 was -91.28%. California Nanotechnologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Nov. 2025 was -126.72%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. California Nanotechnologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2025 was -19.72%.


California Nanotechnologies  (FRA:R14) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

California Nanotechnologies's annualized ROC % for the quarter that ended in Nov. 2025 is calculated as:

ROC % (Q: Nov. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Aug. 2025 ) + Invested Capital (Q: Nov. 2025 ))/ count )
=-2.856 * ( 1 - 0% )/( (3.218 + 3.04)/ 2 )
=-2.856/3.129
=-91.28 %

where

Note: The Operating Income data used here is four times the quarterly (Nov. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

California Nanotechnologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Nov. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Nov. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Aug. 2025  Q: Nov. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-3.664/( ( (2.859 + max(0.197, 0)) + (2.727 + max(-0.008, 0)) )/ 2 )
=-3.664/( ( 3.056 + 2.727 )/ 2 )
=-3.664/2.8915
=-126.72 %

where Working Capital is:

Working Capital(Q: Aug. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.593 + 0 + 0.059) - (0.394 + 0.001 + 0.06)
=0.197

Working Capital(Q: Nov. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.466 + 0 + 0.038) - (0.513 + 0 + -0.001)
=-0.008

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Nov. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

California Nanotechnologies's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Nov. 2025 )
=-1.645/8.342
=-19.72 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


California Nanotechnologies EBIT Related Terms


California Nanotechnologies EBIT Historical Data

* Premium members only.

The historical data trend for California Nanotechnologies's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

California Nanotechnologies EBIT Chart

California Nanotechnologies Annual Data
Trend Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.05 0.24 0.18 0.45 0.19

California Nanotechnologies Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 -0.13 -0.37 -0.22 -0.92

FRA:R14 vs LIN, SHW, ECL: EBIT Comparison

For the Specialty Chemicals subindustry, California Nanotechnologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


California Nanotechnologies EV-to-EBIT vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, California Nanotechnologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where California Nanotechnologies's EV-to-EBIT falls into.


FRA:R14
40GF Score
California Nanotechnologies Corp FRA:R14
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

California Nanotechnologies EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €-1.65 Mil mean?
California Nanotechnologies (FRA:R14) has a EBIT of €-1.65 Mil as of Nov. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on California Nanotechnologies.
Is California Nanotechnologies' EBIT too high?
California Nanotechnologies' current EBIT is €-1.65 Mil. Overall, California Nanotechnologies has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does California Nanotechnologies' EBIT compare to LIN and SHW?
California Nanotechnologies' EBIT of €-1.65 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Chemicals company?
A good EBIT depends on the Chemicals industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on California Nanotechnologies. California Nanotechnologies's current EBIT is €-1.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is California Nanotechnologies stock overvalued right now?
Based on GuruFocus' analysis, California Nanotechnologies (FRA:R14) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.18, compared to a current price of €0.14 — trading 22.2% below its estimated fair value. The current EBIT is €-1.65 Mil. California Nanotechnologies' overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For California Nanotechnologies (FRA:R14), the current EBIT is €-1.65 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is California Nanotechnologies (FRA:R14) Overvalued in 2026?

Based on GuruFocus' analysis, California Nanotechnologies stock appears to be undervalued. The current stock price of €0.14 is trading 22.2% below its estimated GF Value™ of €0.18. GuruFocus considers California Nanotechnologies to be Modestly Undervalued.

Key valuation signals for FRA:R14:

  • EBIT: €-1.65 Mil
  • GF Value™: €0.18 vs. price of €0.14 (22.2% below fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the FRA:R14 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


California Nanotechnologies Business Description

Other Exchanges CANOF:USACNO:Canada
Address 110 Yonge Street, Suite 1601, Toronto, ON, CAN, M5C 1T4
California Nanotechnologies Corp engages in the production, and research and development of nanostructured components and materials. Its products include High-Strength Graphite Spark tooling, Plasma Sintering Tooling, Tungsten Carbide Tooling, Carbon Graphite Foil, Carbon Felt and Yarn, and others.
40GF Score

Get the complete analysis for FRA:R14

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.14
Price
€0.18
GF Value